Scandinavian Medical Solutions (SMSMED.CO) Stock Analysis & AI Equity Report
Scandinavian Medical Solutions (SMSMED.CO) overview
Scandinavian Medical Solutions (SMSMED.CO) stock analysis and AI equity research. For the latest completed financial year, 2025, Scandinavian Medical Solutions reported revenue of DKK 245m and operating profit of DKK 1.8m; the year-end share price was 3.99 DKK and market capitalisation was DKK 110m. Scandinavian Medical Solutions is covered by Valuatum but does not yet have a published AI equity report. Generate a fresh report to get Scandinavian Medical Solutions's valuation, segment value analysis, reverse valuation, financial forecasts, key ratios, risks and catalysts.
Key metrics & valuation multiples
Figures updated on 2026-07-27. Data will be refreshed during report generation.
About Scandinavian Medical Solutions
Scandinavian Medical Solutions A/S buys, sells, and rents pre-owned diagnostic imaging equipment, including MRI, CT, PET/CT, X-ray, and ultrasound systems. It also supplies spare parts and manages related deinstallation, logistics, and aftersales support for hospitals, clinics, and distributors, with operations centered in Denmark and serving international customers.
Generate the Scandinavian Medical Solutions report
Scandinavian Medical Solutions is on Valuatum's coverage list, but a full AI equity report hasn't been generated yet. Order one now for the complete company value map, reverse valuation, risk & catalyst analysis, and financial statements and estimates — plus a downloadable PDF.
Sources & methodology
Financial figures are sourced from Valuatum's financial model for Scandinavian Medical Solutions and represent the latest completed financial year (2025). See the methodology for the full Valuatum AI equity research framework.
Disclaimer: This is an AI-generated research material for informational purposes only. It is not investment advice or a buy/sell recommendation. Always perform your own analysis. Valuatum Oy, Helsinki, Finland.
Analyst reports on Scandinavian Medical Solutions
Each is this company's Valuatum report re-run with an analyst's own assumptions and published under their name. They are ordered by what other analysts said the work added over the engine's report — a score out of five from people who had to read it to give it.